Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (8)

2023

  1. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  2. Fundamental Aspects and Relevance of Components in Antihistamine Eye Drops

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 431-438

  3. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2022

  1. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

2019

  1. Hyaluronic acid combined with serum rich in growth factors in corneal epithelial defects

    International Journal of Molecular Sciences, Vol. 20, Núm. 7

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

2015

  1. Specific association of IL17A genetic variants with panuveitis

    British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570

  2. Study of association of CTLA4 gene variants to non-anterior uveitis

    Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376